These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35779614)

  • 1. Brain-iron deficiency models of restless legs syndrome.
    Earley CJ; Jones BC; Ferré S
    Exp Neurol; 2022 Oct; 356():114158. PubMed ID: 35779614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.
    Allen RP; Earley CJ; Jones BC; Unger EL
    Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome.
    Rodrigues MS; Ferreira SG; Quiroz C; Earley CJ; García-Borreguero D; Cunha RA; Ciruela F; Köfalvi A; Ferré S
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into the Neurobiology of Restless Legs Syndrome.
    Ferré S; García-Borreguero D; Allen RP; Earley CJ
    Neuroscientist; 2019 Apr; 25(2):113-125. PubMed ID: 30047288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA.
    Lanza G; Ferri R
    Adv Pharmacol; 2019; 84():101-119. PubMed ID: 31229167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
    Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
    Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.
    Ferré S; Quiroz C; Guitart X; Rea W; Seyedian A; Moreno E; Casadó-Anguera V; Díaz-Ríos M; Casadó V; Clemens S; Allen RP; Earley CJ; García-Borreguero D
    Front Neurosci; 2017; 11():722. PubMed ID: 29358902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the pathophysiology of restless legs syndrome.
    Earley CJ; Allen RP; Beard JL; Connor JR
    J Neurosci Res; 2000 Dec; 62(5):623-8. PubMed ID: 11104500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome.
    Nanayakkara B; Di Michiel J; Yee BJ
    Aust J Gen Pract; 2023 Sep; 52(9):615-621. PubMed ID: 37666782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical primer on restless legs syndrome: what we know, and what we don't know.
    Sethi KD; Mehta SH
    Am J Manag Care; 2012 Aug; 18(5 Suppl):S83-8. PubMed ID: 23009275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome: update on pathogenesis.
    Dauvilliers Y; Winkelmann J
    Curr Opin Pulm Med; 2013 Nov; 19(6):594-600. PubMed ID: 24048084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.
    Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S
    Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome.
    Walters AS; Li Y; Koo BB; Ondo WG; Weinstock LB; Champion D; Afrin LB; Karroum EG; Bagai K; Spruyt K
    Brain; 2024 Jan; 147(1):26-38. PubMed ID: 37633259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iron-deficient diet on sleep onset and spinal reflexes in a rodent model of Restless Legs Syndrome.
    Woods S; Basco J; Clemens S
    Front Neurol; 2023; 14():1160028. PubMed ID: 37273717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical features of idiopathic restless legs syndrome.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JAG
    Sleep Med Rev; 2019 Jun; 45():70-87. PubMed ID: 30965199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus guidelines on the construct validity of rodent models of restless legs syndrome.
    Salminen AV; Clemens S; García-Borreguero D; Ghorayeb I; Li Y; Manconi M; Ondo W; Rye D; Siegel JM; Silvani A; Winkelman JW; Allen RP; Ferré S;
    Dis Model Mech; 2022 Aug; 15(8):. PubMed ID: 35946581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caenorhabditis elegans and its applicability to studies on restless legs syndrome.
    Chen P; Ijomone OM; Lee KH; Aschner M
    Adv Pharmacol; 2019; 84():147-174. PubMed ID: 31229169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.